A reliable POCT blood test program depends on more than a rapid reaction time. It requires controlled reagent preparation, stable membranes or assay components, consistent sample handling, readable signal development, and quality-controlled packaging. Jiuhe operates as a medical device and consumable supplier with independent production capabilities and an R&D team focused on diagnostic testing technologies. Its portfolio includes immunoassay kits, colloidal gold tests, clinical analyzers, and portable fluorescence immunoassay systems. The company states that applicable products are managed under ISO13485 quality standards, with selected kits designed for 2–30°C storage and a two-year warranty. For practical deployment, a POCT blood test can be selected around the clinical application: HbA1c for diabetes monitoring, D-Dimer for thrombotic-risk assessment, PCT/CRP for inflammatory evaluation, IL-6 for infection-related assessment, or AMH for fertility-related testing. Listed product examples show reading times around 10–15 minutes, supporting workflows where rapid information matters. For international distributors, this combination of product breadth, manufacturing support, and application-focused selection can simplify portfolio development and regional market expansion.